CEO & Founder
EN Rx, Inc.
Erik R. Piatt is the Founder and CEO of EN Rx incorporated in 2001 and also served as the Chief Technical Officer for the first 15 years. Under the direction of Mr. Piatt, EN Rx has developed multiple products for the environmental industry. The current flagship product is the VertebraeTM Segmented Horizontal Well Systems, capable of providing a unique approach to site assessment and remediation with multiple environmental management applications. In addition, Erik co-developed the EN Rx Support Package (SP) for site assessment and reagent injections. Mr. Piatt is a Service-Disabled Veteran having served in Desert Storm as a Sergeant in the United States Marine Corps and has completed most of the requirements for a B.S. in Chemical Engineering.
FLASH POSTER PRESENTATION
Segmented Horizontal Well Systems for Targeted Remediation with ISCO
The deployment of horizontal wells for site assessment and remediation has experienced a revival due to decreased cost and greater flexibility in deployment. The latter is specifically tied to moving from monolithic single well systems, that are subject to preferential path distortions, to segmented well systems. The resultant discretized horizontal profiling brings additional accuracy to assessment at sites, especially those challenged by access issues and also provides more directed treatment operations. Conceptual Site Modela (CSMs) can be significantly enhanced with new perspectives and, on a case by case basis, there can be significant economic advantages. Several case studies will be presented that illuminate the advantages of segmented horizontal well systems, that also incorporate miniaturization and nested bundling methods into the process. The improved flexibility and the integrity of the data sets that are collected and the ability to deliver reagents with improved precision will be illustrated.